Xinrui Pharmaceuticals (06108.HK): Chu Xueping resigns as executive director.

Zhito Finance APP News: New Ray Medicine (06108.HK) announced that, with effect from October 12, 2026, Mr. Chu Xueping has resigned from the position of executive director due to other business pursuits and commitments.